WuXi Bio taps equity market for $795m
WuXi Biologics (Cayman) bagged HK$6.17bn ($795m) on Monday after boosting the size of a new equity issuance.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts